HBK Investments’s NeoGenomics NEO Stock Holding History

HBK Investments’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-131,488	Closed	-$1.66M	–	1251
2018 Q4	$1.66M	Buy	+131,488	New	+$1.96M	0.02%	527

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HBK Investments's NEO Position: Q1 2019 in Review

HBK Investments sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 131,488 shares — an estimated $1.66M sold.

HBK Investments first reported a position in NEO in Q4 2018 and held it in 1 quarter. The position peaked at $1.66M in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

HBK Investments reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
HBK Investments sold 131,488 NeoGenomics shares in Q1 2019, an estimated $1.66M.
HBK Investments first reported a position in NeoGenomics in Q4 2018 and held it in 1 quarter.
HBK Investments's NeoGenomics position peaked at $1.66M in Q4 2018.
235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on HBK Investments's 13F filing for Q1 2019, filed 15 May 2019.